Comparative manufacture and cell-based delivery of antiretroviral nanoformulations. (Q35677168)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22267924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Comparative manufacture and cell-based delivery of antiretroviral nanoformulations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22267924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

main subject

anti-retroviral agent

0 references

author

Upal Roy

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22267924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

10

Alexander V Kabanov

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22267924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

13

Howard E Gendelman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22267924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1

Shantanu Balkundi

1 reference

20 January 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22267924%20AND%20SRC:MED&resulttype=core&format=json

Andrea Martinez-Skinner

5

object named as

Andrea Martinez-Skinner

1 reference

20 January 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22267924%20AND%20SRC:MED&resulttype=core&format=json

2

Ari S Nowacek

1 reference

20 January 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22267924%20AND%20SRC:MED&resulttype=core&format=json

3

Ram S Veerubhotla

1 reference

20 January 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22267924%20AND%20SRC:MED&resulttype=core&format=json

12

JoEllyn McMillan

1 reference

20 January 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22267924%20AND%20SRC:MED&resulttype=core&format=json

Han Chen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22267924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

R Lee Mosley

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22267924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Georgette Kanmogne

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22267924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Xinming Liu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22267924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Tatiana Bronich

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22267924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

English

0 references

publication date

20 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22267924%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Nanomedicine

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22267924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22267924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

3393-3404

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22267924%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial 3.0 Unported

20 January 2020

copyright license

start time

1 December 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

New methods for lipid nanoparticles preparation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

The critical need for alternative antiretroviral formulations, and obstacles to their development

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Cyclosporine a-nanosuspension: formulation, characterization and in vivo comparison with a marketed formulation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Methods development for blood borne macrophage carriage of nanoformulated antiretroviral drugs.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Pharmacotoxicology of monocyte-macrophage nanoformulated antiretroviral drug uptake and carriage

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Atripla®): a review of its use in the management of HIV infection

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Antiretroviral release from poly(DL-lactide-co-glycolide) nanoparticles in mice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Nanoformulated antiretroviral drug combinations extend drug release and antiretroviral responses in HIV-1-infected macrophages: implications for neuroAIDS therapeutics

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Combination antiretroviral drugs in PLGA nanoparticle for HIV-1.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Nanosizing of poorly water soluble compounds using rotation/revolution mixer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

NanoART, neuroAIDS and CNS drug delivery

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

CNS drug delivery systems: novel approaches

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Low atazanavir concentrations in cerebrospinal fluid

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Superoxide dismutase-loaded PLGA nanoparticles protect cultured human neurons under oxidative stress

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

The current status of the NNRTI family of antiretrovirals used in the HAART regime against HIV infection

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy after sustained virologic suppression

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

The pericentriolar recycling endosome plays a key role in Vpu-mediated enhancement of HIV-1 particle release

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Rab9 GTPase is required for replication of human immunodeficiency virus type 1, filoviruses, and measles virus

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Antiretroviral compounds: mechanisms underlying failure of HAART to eradicate HIV-1.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Nanosuspensions in drug delivery

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Determination of indinavir and nelfinavir trough plasma concentration efficacy thresholds according to virological response in HIV-infected patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

In vitro protein adsorption studies on nevirapine nanosuspensions for HIV/AIDS chemotherapy.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Virological and pharmacological factors associated with virological response to salvage therapy after an 8-week of treatment interruption in a context of very advanced HIV disease (GigHAART ANRS 097).

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Immunoarchitecture of lymphoid tissue in HIV-infection during antiretroviral therapy correlates with viral persistence.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophages

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3260033

Universal wet-milling technique to prepare oral nanosuspension focused on discovery and preclinical animal studies - Development of particle design method

23 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22267924

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from the Italian cohort of antiretroviral-naive patients study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22267924

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Macrophage endocytic trafficking of antiretroviral nanoparticles

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22267924

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2147/IJN.S27830

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22267924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22267924%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

PubMed publication ID

22267924

1 reference